Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P LONG

Showing results (81-90 of 273) with videos related to

Pageof 28
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1971
Studies on the nonspecific blocking action of benzyltrimethylammonium bromide (BTM)K Dretchen, F P Diecke, J P Long
European Journal of Pharmacology|January 1, 1972
Effects of 4,4'-biphenylene-bis-(2-oxoethylene)-bis-(2,2-diethoxyethyl) dimethylammonium dibromide (DMAE) on catecholamines released by angiotensinS Greenberg, P J Kadowitz, J P Long
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1984
In vivo and in vitro dopaminergic effects of three ergoline fragmentsJ C Koons, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1977
Inhibition of canine adrenergic transmission by an analog of dopamine: GJH-166F M Sharabi, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Hemicholinium-3 derivatives A-4 and A-5 alter choline metabolism in NB41A3 neuroblastoma cellsK Y Sheff, M A Yorek, J P Long
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonistsK H Park, J P Long, J G Cannon
Life Sciences|January 1, 1994
Noradrenergic mechanisms and the cardiovascular actions of nitroglycerinS X Ma, P G Schmid, J P Long
Journal of Medicinal Chemistry|October 1, 1971
Potential acetylcholinesterase reactivators. p,p-Biphenyl and 1,4-benzene disubstituted oximesC F Barfknecht, F W Benz, J P Long
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1978
Pharmacology of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99). I. Cardiovascular activity in the dog and catJ M Kitzen, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Frequency selective compounds and inhibition of cardiovascular reflexesK H Park, J P Long, J G Cannon
Pageof 28

Showing results (81-90 of 273) with videos related to

Sort By:
Pageof 28
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1971
Studies on the nonspecific blocking action of benzyltrimethylammonium bromide (BTM)K Dretchen, F P Diecke, J P Long
European Journal of Pharmacology|January 1, 1972
Effects of 4,4'-biphenylene-bis-(2-oxoethylene)-bis-(2,2-diethoxyethyl) dimethylammonium dibromide (DMAE) on catecholamines released by angiotensinS Greenberg, P J Kadowitz, J P Long
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1984
In vivo and in vitro dopaminergic effects of three ergoline fragmentsJ C Koons, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1977
Inhibition of canine adrenergic transmission by an analog of dopamine: GJH-166F M Sharabi, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Hemicholinium-3 derivatives A-4 and A-5 alter choline metabolism in NB41A3 neuroblastoma cellsK Y Sheff, M A Yorek, J P Long
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonistsK H Park, J P Long, J G Cannon
Life Sciences|January 1, 1994
Noradrenergic mechanisms and the cardiovascular actions of nitroglycerinS X Ma, P G Schmid, J P Long
Journal of Medicinal Chemistry|October 1, 1971
Potential acetylcholinesterase reactivators. p,p-Biphenyl and 1,4-benzene disubstituted oximesC F Barfknecht, F W Benz, J P Long
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1978
Pharmacology of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99). I. Cardiovascular activity in the dog and catJ M Kitzen, J P Long, J G Cannon
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Frequency selective compounds and inhibition of cardiovascular reflexesK H Park, J P Long, J G Cannon
Pageof 28